Tivic Health Appoints Lisa Wolf as Interim CFO, Effective October 2024

Share This Post

Key Highlights

  • Lisa Wolf appointed as Interim CFO of Tivic Health, effective October 1, 2024.
  • Kimberly Bambach to transition into an advisory role, focusing on strategic transactions.
  • Wolf brings 30 years of financial leadership and over two years with Tivic Health.
  • Tivic Health continues growth in bioelectronic medicine with experienced leadership.

Source: Business Wire

Notable Quote

  • “Lisa has served as a senior member of Tivic’s finance team for over two years, and I am delighted to have her taking on an even more pivotal role. I am also deeply grateful for Kimberly Bambach’s contributions over the past 18 months as we restructured the company to better address current and future market opportunities.” — Jennifer Ernst, CEO at Tivic Health

SoHC's Take

Tivic Health’s appointment of Lisa Wolf as Interim CFO signals a strategic move toward continued financial stability and operational growth. With Wolf’s extensive experience and deep knowledge of the company, Tivic is well-positioned to advance its bioelectronic medicine initiatives. The retention of Kimberly Bambach in an advisory role ensures that Tivic retains critical expertise during this transition, further strengthening the company’s approach to future strategic transactions. This decision reflects a thoughtful alignment of leadership to support Tivic’s long-term objectives in a competitive health tech landscape.

Heading

Key Highlights CalmWave closes a $5.25M financing round led by Third Prime with contributions from Catalyst by Wellstar, Silver Circle, and ...
/
Key Highlights Alice Koehler appointed Managing Director of OMRON Healthcare North America. Koehler brings 25+ years of global experience in ...
/
Key Highlights Koda Health introduces Kidney Action Planning to support Chronic Kidney Disease (CKD) management with cutting-edge tools. Features include gamified patient ...
/
Key Highlights Northwell Health’s Aging Revolution Summit will take place virtually and in-person in NYC on December 3, 2024. Key themes: Therapeutics, ...
/
Key Highlights $5M Series A funding led by Empactful Capital to fuel growth and innovation. Investment will support product development, strategic accounts, and new market ...
/
Key Highlights New Lantern raises $19M Series A funding, led by Benchmark, totaling $23M raised to date. Platform automates 25% of ...
/

More To Explore

Total
0
Share